Pharmacological comparison of rat and human melanocortin 3 and 4 receptors in vitro

Regulatory Peptides

Volumn 106, Issue 1-3, 2002, Pages 7-12

  Schiöth, Helgi B ^a   Bouifrouri, Amin A ^a,b   Rudzish, Richard ^a,b   Muceniece, Ruta ^b,c   Watanobe, Hajime ^d   Wikberg, Jarl E S ^b   Larhammar, Dan ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UNIVERSITY OF LATVIA   (Latvia)

^d INTERNATIONAL UNIVERSITY OF HEALTH AND WELFARE   (Japan)

Author keywords

cAMP; HS014; Ligand binding; Melanocortin receptor subtypes; MSH; Rat; SHU9119

Indexed keywords

ALPHA INTERMEDIN; BETA INTERMEDIN; BETA INTERMEDIN[11-22][11 (N ACETYLCYSTEINE) 14 [3 (2 NAPHTHYL) DEXTRO ALANINE] 18 CYSTEINE 22 ASPARTIC ACID AMIDE] 11,18 CYCLIC DISULFIDE; CORTICOTROPIN; GAMMA INTERMEDIN; HS024 PEPTIDE; HS028 PEPTIDE; INTERMEDIN; MELANOCORTIN 1 RECEPTOR; MELANOCORTIN 3 RECEPTOR; MELANOCORTIN 4 RECEPTOR; MELANOCORTIN 5 RECEPTOR; N ACETYL ALPHA INTERMEDIN[4-10]CYCLO[4 NORLEUCINE 5 ASPARTIC ACID 7 [3 (2 NAPHTHYL)ALANINE] 10 LYSINAMIDE]; NDP PEPTIDE; PEPTIDE MTII; UNCLASSIFIED DRUG; CORTICOTROPIN RECEPTOR; CYCLIC AMP; LIGAND;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL LINE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MAMMAL CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; RECEPTOR BINDING; SPECIES DIFFERENCE; ANIMAL; BINDING COMPETITION; CELL STRAIN COS1; CYTOLOGY; DRUG EFFECT; GENETICS; HYPOTHALAMUS; METABOLISM; PROTEIN BINDING;

ALPHA-MSH; ANIMAL; BINDING, COMPETITIVE; COMPARATIVE STUDY; COS CELLS; CYCLIC AMP; HUMAN; HYPOTHALAMUS; LIGANDS; PROTEIN BINDING; RATS; RECEPTORS, CORTICOTROPIN; SUPPORT, NON-U.S. GOV'T; ANIMALS; HUMANS; RECEPTOR, MELANOCORTIN, TYPE 3; RECEPTOR, MELANOCORTIN, TYPE 4;

MAMMALIA;

EID: 0037096134     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-0115(02)00025-3     Document Type: Article

References (30)

1. The physiological role of melanocortin receptors
2. Brain melanocortin receptors: From cloning to function
3. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
4. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
5. Identification of a receptor for melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system
6. Molecular cloning of a novel melanocortin receptor
7. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor
8. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain
9. A unique metabolic syndrome causes obesity in the melanocortin-3 receptor-deficient mouse
10. Structural diversity of receptors for neuropeptide Y, peptide YY and pancreatic polypeptide
11. The cloned guinea pig pancreatic polypeptide receptor Y4 resembles more the human Y4 than does the rat Y4
12. Single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors
13. Characterisation of melanocortin receptor subtypes by radioligand binding analysis
14. Characterisation of melanocortin 4 receptor by radioligand binding analysis
15. 7] substituted MSH analogues for the melanocortin receptors
16. 10)α-melanocyte-stimulating hormone-(4-10)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors
17. Potent and prolonged acting cyclic lactam analogues of α-melanotropin: Design based on molecular dynamics
18. Discovery of novel melanocortin 4 receptor selective MSH analogues
19. Discovery of a novel superpotent and selective melanocortin-4 receptor antagonist (HS024): Evaluation in vitro and in vivo
20. Long term orexigenic effects of a novel selective MC4 receptor antagonist
21. Morphine down-regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction
22. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid
23. Structural determinants of the melanocortin peptides required for activation of melanocortin-3 and melanocortin-4 receptors
24. Differential effects of melanocortin peptides on neural melanocortin receptors
25. Selective, high affinity peptide antagonists of alpha-melanotropin action at human melanocortin receptor 4: Their synthesis and biological evaluation in vitro
26. Characterizations of the unusual dissociation properties of melanotropin peptides from the melanocortin receptor, hMC1R
27. Autoradiographic discrimination of melanocortin receptors indicates that the MC3 subtype dominates in the medial rat brain
28. The human melanocyte stimulating hormone receptor has evolved to become "super-sensitive" to melanocortin peptides
29. Evidence indicating that the extracellular loops of the mouse MC5 receptor do not participate in ligand binding